TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12699035

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group from RCTs
Number of subjects: 192
Study: 10900811

Group type: EXPERIMENTAL
Intervention: Self-management training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 30
Study: 8612383

Group type: EXPERIMENTAL
Intervention: Buccal mode inhalation technique
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Pulmonary mode inhalation technique
Number of subjects: 14
Study: 1343207

Group type: EXPERIMENTAL
Intervention: Structured evaluation form
Number of subjects: 203

Group type: COMPARATOR
Intervention: Open-ended evaluation form
Number of subjects: 203

Group type: COMPARATOR
Intervention: Instructional videotape
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: General internists
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: University hospital faculty
Number of subjects: 203
Study: 6141436

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy every 8 weeks for 2 years
Number of subjects: 162

Group type: COMPARATOR
Intervention: Observation only
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Patients above 40 years
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Patients aged 40 and below
Number of subjects: 162
Study: 31530065

Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Number of subjects: 70

Group type: COMPARATOR
Intervention: In-person care
Number of subjects: 70
Study: 30238584

Group type: COMPARATOR
Intervention: Tacrolimus ointment plus 308 nm excimer lamp
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment plus 308 nm excimer lamp plus fractional CO2 laser
Number of subjects: 21
Study: 30118569

Group type: EXPERIMENTAL
Intervention: Collagen membrane (CM) with bone substitute
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Concentrated growth factor (CGF) with bone substitute
Number of subjects: 52
Study: 26468626

Group type: EXPERIMENTAL
Intervention: Rotary instrumentation (ProTaper™ S1‐S2‐F1‐F2)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Reciprocating instrumentation (WaveOne™ Primary)
Number of subjects: 47
Study: 25119339

Group type: COMPARATOR
Intervention: Iron supplements (0 mg/kg/d)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Iron supplements (1 mg/kg/d)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Iron supplements (2 mg/kg/d)
Number of subjects: 285
Study: 22892751

Group type: EXPERIMENTAL
Intervention: ParaCore (PAR)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: ParaCore + silane (PAR-SIL)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: RelyX Unicem (RXU)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: RelyX Unicem + silane (RXU-SIL)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: RelyX ARC (RXA)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: RelyX ARC + silane (RXA-SIL)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Negative control (NEG-CON)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Positive control (POS-CON)
Number of subjects: 56
Study: 20488346

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT), 10 sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 18833859

Group type: EXPERIMENTAL
Intervention: Group 1: Intact teeth (no preparation)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group 2: Non-restored teeth
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group 3: Restored with amalgam
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group 4: Restored with dentin bonding system (DBS) and resin composite (CR)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group 5: Restored with indirect hybrid ceramic inlay material
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group 6: Restored with polyethylene ribbon fiber and DBS/CR
Number of subjects: 60
Study: 15891932

Group type: EXPERIMENTAL
Intervention: Problem-based learning (PBL)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Structured course (SC)
Number of subjects: 98
Study: 11838889

Group type: EXPERIMENTAL
Intervention: Food service intervention (training workshops for cooks and monthly site visits)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Food service intervention
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 9
Study: 10367619

Group type: EXPERIMENTAL
Intervention: Cytokine production of IL-1 per monocyte
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cytokine production of IL-6 per monocyte
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cytokine production of TNF-alpha per monocyte
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cytokine production of IFN-gamma per lymphocyte
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cytokine production of G-CSF
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Lymphocyte proliferative response with PHA
Number of subjects: 34
Study: 7564843

Group type: EXPERIMENTAL
Intervention: Pharyngeal constrictor myotomy
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Unilateral pharyngeal plexus neurectomy
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Unilateral pharyngeal plexus neurectomy with small drainage myotomy limited to the cricopharyngeus
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 29
Study: 1981698

Group type: EXPERIMENTAL
Intervention: 0.50 mg etizolam
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 0.25 mg etizolam
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 7033788

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 30782877

Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training for approximately 5 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 100
Study: 28414728

Group type: EXPERIMENTAL
Intervention: Clown-care (n = 20)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard-care (n = 25)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Clown-care followed by Standard-care
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Injection-naïve children with clown-care
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Multiple procedures with clown-care
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard-care first experience
Number of subjects: 45
Study: 25867700

Group type: EXPERIMENTAL
Intervention: ProTaper Next
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: TF Adaptive
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: WaveOne
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Reciproc
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: OneShape
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: SAF
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control
Number of subjects: 70
Study: 23953024

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 1843

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 1843

Group type: COMPARATOR
Intervention: MoodGYM (active control)
Number of subjects: 1843
Study: 21272417

Group type: EXPERIMENTAL
Intervention: Nurse practitioners (NP) lifestyle counselling
Number of subjects: 341

Group type: COMPARATOR
Intervention: Usual care from general practitioners (GP-UC)
Number of subjects: 341
Study: 19961603

Group type: EXPERIMENTAL
Intervention: Physiotherapy, corticosteroid injection, and naproxen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physiotherapy, placebo injection, and naproxen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait and see treatment with naproxen alone
Number of subjects: 0
Study: 17143826

Group type: EXPERIMENTAL
Intervention: usZDV/sdNVP
Number of subjects: 609

Group type: COMPARATOR
Intervention: sdNVP
Number of subjects: 609
Study: 15128682

Group type: EXPERIMENTAL
Intervention: Empirical treatment with omeprazole and serological H.pylori testing
Number of subjects: 199

Group type: COMPARATOR
Intervention: Prompt upper gastrointestinal endoscopy
Number of subjects: 199

Group type: COMPARATOR
Intervention: Prompt upper gastrointestinal radiography
Number of subjects: 199
Study: 12028831

Group type: EXPERIMENTAL
Intervention: Positive selection (CD34 selection alone)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Positive/negative selection (CD34 selection followed by breast cancer cell depletion)
Number of subjects: 101
Study: 9566670

Group type: EXPERIMENTAL
Intervention: Low-dose prednisolone (average 6.0+/−0.2 mg daily)
Number of subjects: 19
Study: 8313822

Group type: EXPERIMENTAL
Intervention: Erythromycin (150 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atropine (12 micrograms/kg)
Number of subjects: 0
Study: 3417465

Group type: EXPERIMENTAL
Intervention: Experimental group with access to PEFR information
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 29301556

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 72
Study: 26566091

Group type: EXPERIMENTAL
Intervention: Continuous chest compressions at a rate of 120 min−1 with asynchronous ventilations (CCaV-120)
Number of subjects: 17

Group type: COMPARATOR
Intervention: 3:1 chest compression to ventilation (C:V) ratio
Number of subjects: 17
Study: 24751173

Group type: EXPERIMENTAL
Intervention: Coaches who attended 2 coach education sessions
Number of subjects: 80

Group type: COMPARATOR
Intervention: No treatment control (coaches who did not receive coach education sessions)
Number of subjects: 80
Study: 23517933

Group type: COMPARATOR
Intervention: Adalimumab induction (160/80 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adalimumab maintenance (40 mg every-other-week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22319691

Group type: EXPERIMENTAL
Intervention: Steroid-antibiotic
Number of subjects: 82

Group type: COMPARATOR
Intervention: 10% Ichthammol glycerine pack
Number of subjects: 82
Study: 18466276

Group type: EXPERIMENTAL
Intervention: Microwave disinfection (650 W for 6 min, three times per week for 30 days)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Microwave disinfection + topical miconazole (three times per day for 30 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical miconazole (three times per day for 30 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (routine denture care)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Microwave disinfection
Number of subjects: 60
Study: 17460558

Group type: EXPERIMENTAL
Intervention: Sirolimus (n=31)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Cyclosporine (n=30)
Number of subjects: 61
Study: 12963662

Group type: EXPERIMENTAL
Intervention: Minilaparoscopic cholecystectomy (MLC)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 5-mm laparoscopic cholecystectomy (5-mm LC)
Number of subjects: 90
Study: 10960945

Group type: EXPERIMENTAL
Intervention: Paclitaxel (200 mg/m2 i.v. 3-hour infusion on day 1) + Carboplatin (AUC 6)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Paclitaxel (200 mg/m2 i.v. 3-hour infusion on day 1) + Gemcitabine (1,000 mg/m2 on days 1 and 8)
Number of subjects: 127
Study: 9376155

Group type: EXPERIMENTAL
Intervention: Powdered budesonide
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard aerosol
Number of subjects: 66
Study: 8159877

Group type: EXPERIMENTAL
Intervention: Cephalothin and clindamycin
Number of subjects: 42

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate
Number of subjects: 42
Study: 2419693

Group type: EXPERIMENTAL
Intervention: Pafenolol 50 mg once daily
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Pafenolol 100 mg once daily
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 30365470

Group type: EXPERIMENTAL
Intervention: Cold-water immersion at 10°C for 10 minutes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no cold-water immersion)
Number of subjects: 30
Study: 25376194

Group type: EXPERIMENTAL
Intervention: Guanfacine Extended Release (GXR)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 27444425

Group type: EXPERIMENTAL
Intervention: Integrated treatment (Motivational Enhancement Therapy and Prolonged Exposure delivered concurrently)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Sequential treatment (Motivational Enhancement Therapy and Prolonged Exposure delivered sequentially)
Number of subjects: 183
Study: 25261164

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (25 μg/d)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (10 μg/d)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study: 22589439

Group type: EXPERIMENTAL
Intervention: Macular color fundus photography (CFP) hyperpigmentation
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: CFP hyperpigmentation in 20 study eyes
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: SDOCT regions with hyperreflective foci in another subset of 20 eyes
Number of subjects: 314
Study: 20543019

Group type: EXPERIMENTAL
Intervention: Traditional therapy plus proprioceptive neuromuscular facilitation plus neuromobilization (Experimental group 2)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Traditional therapy plus proprioceptive neuromuscular facilitation (Experimental group 1)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Traditional therapy (Control group)
Number of subjects: 96
Study: 19115912

Group type: EXPERIMENTAL
Intervention: Acetazolamide 250 mg/day (125 mg bid)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 15825909

Group type: EXPERIMENTAL
Intervention: Type A Behavior Pattern assessment using the Jenkins Activity Survey, Form H
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no history of psychiatric sick-leaves)
Number of subjects: 200
Study: 12939216

Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg on alternate days)
Number of subjects: 22071

Group type: EXPERIMENTAL
Intervention: NSAIDs (1 to 59 days/year)
Number of subjects: 22071

Group type: EXPERIMENTAL
Intervention: NSAIDs (≥60 days/year)
Number of subjects: 22071

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22071
Study: 10376499

Group type: EXPERIMENTAL
Intervention: Early ambulation after diagnostic cardiac catheterization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (not explicitly mentioned)
Number of subjects: 0
Study: 8664135

Group type: EXPERIMENTAL
Intervention: New Patient Information Package (NPIP)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Mini version of the same package (mini‐NPIP)
Number of subjects: 304

Group type: COMPARATOR
Intervention: No information package (Control)
Number of subjects: 304
Study: 1738766

Group type: EXPERIMENTAL
Intervention: Heart Smart environmental intervention including a school lunch program providing cardiovascular healthful food choices, reduced in fat by 30% and in sodium and sugar by 50%; physical education program promoting personal fitness and aerobic conditioning; cardiovascular risk factor screening.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heart Smart environmental intervention (school lunch program).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heart Smart environmental intervention (physical education program).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heart Smart environmental intervention (overall program).
Number of subjects: 0
Study: 6383614

Group type: EXPERIMENTAL
Intervention: Long-term drug therapy (cyclophosphamide)
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Short-term drug therapy (cyclophosphamide)
Number of subjects: 461

Group type: COMPARATOR
Intervention: No drug therapy
Number of subjects: 461
Study: 31860203

Group type: COMPARATOR
Intervention: Standard low-calorie diet (1730 kcal, protein - 87.4 g, fat - 61.4 g, carbohydrates - 207 g)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Personalized diet (2125 kcal, protein - 100.2 g, fat - 75.9 g, carbohydrates - 260 g) with modification of protein component
Number of subjects: 50
Study: 29069507

Group type: EXPERIMENTAL
Intervention: Mavrilimumab (30, 100 or 150 mg)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Mavrilimumab (150 mg)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Mavrilimumab
Number of subjects: 305

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 305
Study: 26549249

Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg twice daily
Number of subjects: 1255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1255
Study: 24589826

Group type: EXPERIMENTAL
Intervention: Housing First intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 60
Study: 22457372

Group type: EXPERIMENTAL
Intervention: Pre-operative visits and counselling by ICU nurses
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine pre-operative counselling by surgeons only (Control)
Number of subjects: 120
Study: 19580457

Group type: EXPERIMENTAL
Intervention: Intensive bisphosphonate therapy
Number of subjects: 1324

Group type: COMPARATOR
Intervention: Symptomatic treatment
Number of subjects: 1324
Study: 19227421

Group type: EXPERIMENTAL
Intervention: Maternal presence during anesthesia induction (Group M)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Maternal absence during anesthesia induction (Group C)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups (Group M and Group C)
Number of subjects: 100
Study: 16376757

Group type: EXPERIMENTAL
Intervention: Dual-triggered (DT) acquisition
Number of subjects: 20

Group type: COMPARATOR
Intervention: Continuous imaging (CIM)
Number of subjects: 20
Study: 11890871

Group type: EXPERIMENTAL
Intervention: Enzyme replacement therapy (ERT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Symptomatic management
Number of subjects: 0
Study: 9472182

Group type: EXPERIMENTAL
Intervention: Ipratropium plus albuterol (initial dose of albuterol 2.5 mg followed by 2 more doses at 20-min intervals, ipratropium 0.5 mg combined with the initial dose of albuterol)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Albuterol alone (2.5 mg initial dose followed by 2 more doses at 20-min intervals)
Number of subjects: 55
Study: 8585220

Group type: EXPERIMENTAL
Intervention: Wobe-Mugos (tablets)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Wobe-Mugos (dragees)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 2504075

Group type: EXPERIMENTAL
Intervention: Midazolam (0.4 mg/kg) and Innovar (0.04 ml/kg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Chlorprothixene (2.0 mg/kg)
Number of subjects: 36
Study: 1091393

Group type: EXPERIMENTAL
Intervention: Pentobarbital 60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pentobarbital 180 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diphenhydramine 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diphenhydramine 150 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methapyrilene 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pentobarbital 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31337369

Group type: EXPERIMENTAL
Intervention: Nomogram based on age, location of carcinoma, tumor grade, TNM stage, size of carcinoma, lymph node ratio (LNR)
Number of subjects: 6341

Group type: EXPERIMENTAL
Intervention: Nomogram-predicted probability score (≥20, 10-19 and <10)
Number of subjects: 6341
Study: 28049480

Group type: EXPERIMENTAL
Intervention: Occupational therapy rehabilitation program with coaching based on cognitive behavioral therapy (CBT) principles (OTc)
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Sensor monitoring added to the occupational therapy intervention (OTcsm)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 288
Study: 25847578

Group type: EXPERIMENTAL
Intervention: tMBSR
Number of subjects: 63

Group type: COMPARATOR
Intervention: tSupport
Number of subjects: 63
Study: 23632670

Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion (ABT)
Number of subjects: 204

Group type: COMPARATOR
Intervention: No-drainage
Number of subjects: 204
Study: 21321491

Group type: EXPERIMENTAL
Intervention: 3-4 diaminopyridine (DAP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 19016463

Group type: EXPERIMENTAL
Intervention: Narrow-band blue-light therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Red-light therapy (control)
Number of subjects: 30
Study: 16510061

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pantoprazole (Protonix)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: H2RAs or PPIs (maintenance therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic antireflux surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upper endoscopy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PPIs as a class
Number of subjects: 0
Study: 10553391

Group type: EXPERIMENTAL
Intervention: Ignition interlock program
Number of subjects: 1387

Group type: COMPARATOR
Intervention: Conventional postlicensing treatment program (control)
Number of subjects: 1387

Group type: EXPERIMENTAL
Intervention: Post-interlock period (after unrestricted driving privileges were returned)
Number of subjects: 1387
Study: 8552800

Group type: EXPERIMENTAL
Intervention: Concrete objective information based on self‐regulation theory
Number of subjects: 62

Group type: COMPARATOR
Intervention: Self‐care instruction
Number of subjects: 62
Study: 1913768

Group type: EXPERIMENTAL
Intervention: 40% chlorhexidine varnish
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 33% chlorhexidine varnish
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 25% chlorhexidine varnish
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 0% chlorhexidine varnish
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 40% chlorhexidine varnish (removed after 15 min)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 40% chlorhexidine varnish (left on for 8 h)
Number of subjects: 11